IP Library › Granted Patent US 12,357,019
Granted Patent B2
US 12,357,019 · App. 18/452,662 · Granted Jul 15, 2025

Soft oral product

Inventors: Munmaya K. Mishra (Manakin Sabot, VA); Georgios D. Karles (Richmond, VA)
Assignee: Altria Client Services LLC
A24B15/283A24B13/00A24B15/301A24B15/302A24B15/303A24B15/308A24B15/365A61K9/0056A61K9/0058A61K47/32A61K47/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,019
App. No.
18/452,662
Granted
Jul 15, 2025
Kind
B2
Abstract

An oral product includes a body that is wholly receivable in an oral cavity. The body includes a polymer matrix and one or more flavorants and/or active ingredients embedded in the polymer matrix. The polymer matrix can include a copolymer of ethylene and one or more vinyl monomers or zein. For example, the polymer can be ethylene-vinyl acetate copolymer and/or ethylene-vinyl alcohol copolymer. In some cases, the oral product can include tobacco and/or nicotine.

Claims (43)

1. An oral product comprising:

a polymer matrix including a copolymer of ethylene and a vinyl monomer, zein, gelatin, or any combination thereof;

an alkaloid;

a triglyceride including,

medium chain triglycerides; and

a cellulosic material including,

microcrystalline cellulose.

2. The oral product of claim 1 , further comprising:

a vitamin.

3. The oral product of claim 1 , further comprising:

a dietary supplement.

4. The oral product of claim 1 , further comprising:

an amino acid.

5. The oral product of claim 1 , further comprising:

a mineral.

6. The oral product of claim 1 , wherein the triglyceride is present in an amount less than or equal to 20 weight percent.

7. The oral product of claim 1 , wherein the triglyceride is present in an amount ranging from 0.5 weight percent to 10 weight percent.

8. The oral product of claim 1 , further comprising:

a flavorant.

9. The oral product of claim 8 , wherein the flavorant is an encapsulated flavorant.

10. The oral product of claim 1 , further comprising:

a sweetener.

11. The oral product of claim 10 , wherein the sweetener includes saccharine, sucralose, aspartame, acesulfame potassium, or any combination thereof.

12. The oral product of claim 1 , wherein the polymer matrix includes the copolymer of ethylene and the vinyl monomer.

13. The oral product of claim 12 , wherein the copolymer of ethylene and the vinyl monomer includes vinyl acetate in an amount ranging from 25 weight percent to 40 weight percent.

14. The oral product of claim 12 , wherein the copolymer of ethylene and the vinyl monomer is amorphous.

15. An oral product comprising:

a polymer matrix including a copolymer of ethylene and a vinyl monomer, zein, gelatin, or any combination thereof;

an energizing agent;

a triglyceride including,

medium chain triglycerides; and

a cellulosic material including,

microcrystalline cellulose.

16. The oral product of claim 15 , further comprising:

an additive including a mineral, a vitamin, a dietary supplement, a nutraceutical, a soothing agent, a coloring agent, an amino acid, a chemesthesis agent, an antioxidant, a food-grade emulsifier, a pH modifier, a botanical, a teeth whitening agent, a therapeutic agent, or any combination thereof.

17. The oral product of claim 15 , wherein the triglyceride is present in an amount less than or equal to 20 weight percent.

18. The oral product of claim 15 , further comprising:

a flavorant, and

a sweetener.

19. The oral product of claim 15 , wherein the polymer matrix includes the copolymer of ethylene and a vinyl monomer.

20. The oral product of claim 19 , wherein

the copolymer of ethylene and the vinyl monomer includes vinyl acetate in an amount ranging from 25 weight percent to 40 weight percent, and

the polymer matrix includes the copolymer of ethylene and a vinyl monomer.

Continuity (6)
Continuation 17075026 · Oct 20, 2020
Continuation 16371219 · Apr 1, 2019
Continuation 15220604 · Jul 27, 2016
Division 14206541 · Mar 12, 2014
Provisional Application 61786195 · Mar 14, 2013
Related Publication 20230389596A1 · Dec 7, 2023
References Cited (66)
US 2162738A · McCoy · 1939 [cited by applicant]
US 3139436A · Bicking · 1964 [cited by applicant]
US 3396735A · Von Bethmann et al. · 1968 [cited by applicant]
US 4153063A · Roselius et al. · 1979 [cited by applicant]
US 4448208A · Friedrich et al. · 1984 [cited by applicant]
US 4515769A · Merritt et al. · 1985 [cited by applicant]
US 4516590A · Teng · 1985 [cited by applicant]
US 4528993A · Sensabaugh, Jr. et al. · 1985 [cited by applicant]
US 4660577A · Sensabaugh et al. · 1987 [cited by applicant]
US 4848373A · Lenkey · 1989 [cited by applicant]
US 4987907A · Townend · 1991 [cited by applicant]
US 5372149A · Roth et al. · 1994 [cited by applicant]
US 5487792A · King et al. · 1996 [cited by applicant]
US 5545414A · Behr et al. · 1996 [cited by applicant]
US 6010720A · Derrieu et al. · 2000 [cited by applicant]
US 6344222B1 · Cherukuri et al. · 2002 [cited by applicant]
US 6596298B2 · Leung et al. · 2003 [cited by applicant]
US 6613833B2 · Kawahara et al. · 2003 [cited by applicant]
US 7524895B2 · Ikeda et al. · 2009 [cited by applicant]
US 9420827B2 · Mishra · 2016 [cited by examiner]
US 10244787B2 · Mishra · 2019 [cited by examiner]
US 10834960B2 · Mishra · 2020 [cited by examiner]
US 20030049318A1 · Davis et al. · 2003 [cited by applicant]
US 20030206942A1 · Kulkarni et al. · 2003 [cited by applicant]
US 20030211136A1 · Kulkarni · 2003 [cited by examiner]
US 20040052851A1 · Graff et al. · 2004 [cited by applicant]
US 20040118422A1 · Lundin et al. · 2004 [cited by applicant]
US 20050178398A1 · Breslin et al. · 2005 [cited by applicant]
US 20060198873A1 · Chan et al. · 2006 [cited by applicant]
US 20080187621A1 · Boghani et al. · 2008 [cited by applicant]
US 20080209586A1 · Nielsen et al. · 2008 [cited by applicant]
US 20080286340A1 · Andersson · 2008 [cited by examiner]
US 20090025739A1 · Brinkley et al. · 2009 [cited by applicant]
US 20090095313A1 · Fuisz · 2009 [cited by applicant]
US 20090098192A1 · Fuisz · 2009 [cited by applicant]
US 20090196834A1 · Andersen · 2009 [cited by applicant]
US 20100255064A1 · Andersen et al. · 2010 [cited by applicant]
US 20100266669A1 · Meyer et al. · 2010 [cited by applicant]
US 20100282267A1 · Atchley · 2010 [cited by applicant]
US 20100291245A1 · Gao et al. · 2010 [cited by applicant]
US 20100326454A1 · Fuisz · 2010 [cited by applicant]
US 20110083688A1 · Mishra et al. · 2011 [cited by applicant]
US 20110108043A1 · Ettireddy et al. · 2011 [cited by applicant]
US 20120318287A1 · Andersen · 2012 [cited by applicant]
US 20130186417A1 · Gao et al. · 2013 [cited by applicant]
GB 1176667A · 1970 [cited by applicant]
WO WO2006000232A1 · 2006 [cited by applicant]
WO WO2008002691A2 · 2008 [cited by applicant]
Definition of “matrix”. The Free Dictionary, no date, [online], retrieved from the Internet, [retrieved Oct. 11, 2017], <URL: http://www.thefreedictionary.com/matrix>. (Year: 2017). [cited by examiner]
International Preliminary Report on Patentability in International Application No. PCT/US2014/024683, mailed Sep. 24, 2015, 14 pages. [cited by applicant]
Japanese Office Action in Application No. 2016-501603, dated Nov. 8, 2017, 9 pages. [cited by applicant]
Takahashi, et al. “Crystal Structure of Ethylene-Vinyl Alcohol Copolymers,” Macromolecules, 32, pp. 5860-5871 (1999). [cited by applicant]
Tso, “Chapter 1:Seed to Smoke,” Tobacco, Production, Chemistry and Technology, Davis & Nielsen, Eds. 1999, 33 pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2014/024683 dated Oct. 14, 2014. [cited by applicant]
International Preliminary Report and Written Opinion for corresponding Application No. PCT/US2014/024683 dated Sep. 15, 2015. [cited by applicant]
Definition of “matrix”, The Free Dictionary, no date, [online], retrieved from the Internet, Oct. 11, 2017, <URL:http://www.thefreedictionary.com/matrix>. [cited by applicant]
Japanese Notice of Reasons for Rejection for corresponding Application No. 2018-173226, dated Nov. 18, 2019, English translation thereof. [cited by applicant]
Non-Final Office Action issued Aug. 11, 2015 in U.S. Appl. No. 14/206,541. [cited by applicant]
Non-Final Office Action issued Nov. 24, 2015 in U.S. Appl. No. 14/206,541. [cited by applicant]
Notice of Allowance issued Apr. 27, 2016 in U.S. Appl. No. 14/206,541. [cited by applicant]
Non-Final Office Action issued Feb. 21, 2018 in U.S. Appl. No. 15/220,604. [cited by applicant]
Final Office Action issued Aug. 2, 2018 in U.S. Appl. No. 15/220,604. [cited by applicant]
Notice of Allowance issued Dec. 3, 2018 in U.S. Appl. No. 15/220,604. [cited by applicant]
Non-Final Office Action issued Apr. 8, 2020 in U.S. Appl. No. 16/371,219. [cited by applicant]
Notice of Allowance issued Jul. 23, 2020 in U.S. Appl. No. 16/371,219. [cited by applicant]
Kamath etal,“Crystallinity of ethylene-vinyl acetate copolymers” J. Applied Science, V9, pp. 3153-3160, 1965, [online] retrieved from the Internet, [retrieved Jan. 9, 2023], <https://onlinelibrary.wiley.com/doi/epdf/10.… [cited by applicant]